Press Releases
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form... (continue reading...)MONACO, May 10, 2024 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the first quarter ended March 31, 2024 (“Q1 2024”).
I. PROFITABILITY AND LIQUIDITY
- Q1 2024 Net Income available to common stockholders of $94.2 million ($0.79 per share).
- Q1 2024 Adjusted Net Income available to common stockholders1 of $75.2 million ($0.63 per share).
- Q1 2024 liquidity of $1,106.0... (continue reading...)
Q1 2024 revenues were $5.8 million, up 53% from Q1 2023
Q1 2024 gross margin was 73%, up 600bp from Q1 2023
Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023
Company provides guidance for revenue growth of 45-55% for Q2 2024 versus Q2 2023 and reiterates revenue growth guidance of 50% for FY 2024 compared to FY 2023
EDEN PRAIRIE, MN - (NewMediaWire) - May 10, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE) (OTCQB: SNWV), a... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form... (continue reading...)More Press Releases
View Older Stories-
LKQ Corporation Executes Agreement to Sell Elit Polska in Poland to MEKO AB
-
Minister Ebrahim Patel to Visit Hisense South Africa Factory
-
VerticalScope to Participate in Upcoming Investor Conferences in May and June 2024
-
Mondee Reports First Quarter 2024 Results
-
Flash News: OKX Launches "Space Nation x OKX Exploration Ship NFT Allowlist Giveaway"
-
Bayridge Resources Completes Cash and Share Obligations Towards Initial 40% Earn-In at Its Athabasca Basin Uranium Properties
-
Goodbaby International Holdings Limited Announces First Quarter Revenue Performance
-
Weekly Recap: 13 Press Releases You Might Have Missed
-
Canlan Reports Record Q1 Revenue
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL DISTRIBUTIONS - Ordinary Shares
-
Canaan Inc. to Report First Quarter 2024 Financial Results on May 17, 2024
-
KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time
-
Hello Group to Report First Quarter 2024 Results on May 28, 2024
-
Media advisory: NS Police Officers will Receive Constable Heidi Stevenson’s Watch Award on May 13
-
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
-
ChipMOS REPORTS APRIL 2024 YEAR-OVER-YEAR REVENUE GROWTH
-
CBAK Energy Reports First Quarter 2024 Unaudited Financial Results
-
Consumers Spend 30% of Monthly Food Budgets on Restaurants, Down from 40% in 2022, Popmenu Study Finds
-
Baozun Schedules Annual General Meeting of Shareholders
-
Pivotree Announces First Quarter 2024 Results
-
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration
-
Defiance Launches USOY, The First Oil Enhanced Options Income ETF.
-
Yalla Group Limited to Report First Quarter 2024 Financial Results on May 20, 2024 Eastern Time
-
Advanced Energy to Participate at Upcoming Investor Conferences
-
American Strategic Investment Co. Announces First Quarter 2024 Results
-
NHC Reports First Quarter 2024 Earnings
-
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell The
-
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
Experian Earns HR Tech Award From Lighthouse Research & Advisory
-
Agora, Inc. to Report First Quarter 2024 Financial Results on May 22, 2024
-
Bilibili Inc. to Report First Quarter 2024 Financial Results on Thursday, May 23, 2024
-
Digihost to Announce Q1 Results on May 14th
-
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
-
AirSculpt Technologies Reports for First Quarter Earnings
-
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
-
Enovis to Participate in Upcoming Investor Conferences
-
Net Asset Value(s)
-
IOTSWC unveils the latest disruptive technologies for industrial transformation
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc
-
The Renowned Port City of Ningbo Reopened the Window for International Exchanges with Unveiled Ningbo International Communication Center
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Genflow Biosciences PLC Announces Holding(s) in Company
-
Sonida Enhances Executive Team and Board to Support Company Growth
-
Momcozy Celebrates Mother’s Day With Ongoing Savings in the Momcozy Village
-
ZEEKR Intelligent Technology Holding Limited Announces Pricing of its Initial Public Offering
-
Alcohol Justice Joins Alcohol Policy 20 Conference in Washington, D.C.
-
NVIDIA CEO Jensen Huang to Deliver Keynote Ahead of COMPUTEX 2024
-
Sonida Senior Living Announces First Quarter 2024 Results